22157.jpg
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Forecast and Competitive Analysis to 2034
18 mars 2024 05h37 HE | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034"...
22157.jpg
Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies
24 janv. 2024 10h32 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
22157.jpg
Global Dyslipidemia Disease Analysis 2020-2027 - Market is Poised to Resume Steady Growth Due to the Introduction of Novel Agents
23 mars 2021 08h03 HE | Research and Markets
Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Dyslipidemia" report has been added to ResearchAndMarkets.com's offering. The report estimates that in 2018, there were...
22157.jpg
Worldwide Hyperlipidemia Drugs Industry to 2025 - by Drug Type, End-user and Region
12 févr. 2021 06h23 HE | Research and Markets
Dublin, Feb. 12, 2021 (GLOBE NEWSWIRE) -- The "Hyperlipidemia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...